MedPath

Observational study on the efficacy of multimodal complex therapy and Viscum album extract in the treatment of patients with advanced lung cancer

Conditions
C34
Malignant neoplasm of bronchus and lung
Registration Number
DRKS00022891
Lead Sponsor
Forschungsinstitut Havelhöhe gGmbH
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
101
Inclusion Criteria

Expected three months participation in ACCEPT possible
German language
Once a week in hospital Participation in the education program

Exclusion Criteria

No German language
Expected to last less than three months
Mobility to weekly therapy not given

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Feasibility of ACCEPT: Number of patients who can complete the program as specified and do not prematurely discontinue therapy and allow the quality of life measurement to be answered using the FACT-L questionnaire
Secondary Outcome Measures
NameTimeMethod
Feasibility of randomisation<br>Measurability of the Qo
© Copyright 2025. All Rights Reserved by MedPath